Creoptix
Wädenswil, CH · 2 known investors
Find your way into Creoptix
Sign up to see every warm intro you have to Creoptix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Creoptix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Creoptix, a Malvern Panalytical brand, develops bioanalytical instruments for molecular interaction analysis, including its WAVE biosensor system for real-time kinetics and affinity studies of molecules such as small molecules, peptides, and proteins. Its tools serve drug discovery and life sciences research for both industry and academia.
Founders & leadership
Investors · 2
Funding
SEC filings, press & company announcements- Undisclosed amountSeries CSep 2019Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Creoptix do?
- Creoptix, a Malvern Panalytical brand, develops bioanalytical instruments for molecular interaction analysis, including its WAVE biosensor system for real-time kinetics and affinity studies of molecules such as small molecules, peptides, and proteins. Its tools serve drug discovery and life sciences research for both industry and academia.
- Who founded Creoptix?
- Creoptix was founded by Kaspar Cottier.
- Who are Creoptix's investors?
- Creoptix's investors include Privilège Ventures, StartAngels Network.
- Where is Creoptix headquartered?
- Creoptix is headquartered in Wädenswil, CH.

